Skip to main content
PMC home page
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 1988 Jan;1(1):124–138. doi: 10.1128/cmr.1.1.124

Practical diagnostic testing for human immunodeficiency virus.

J B Jackson 1, H H Balfour Jr 1
PMCID: PMC358034  PMID: 3060241

Abstract

Since the discovery of human immunodeficiency virus (HIV) as the causative agent of acquired immunodeficiency syndrome in 1983, there has been a proliferation of diagnostic tests. These assays can be used to detect the presence of HIV antibody, HIV antigen, HIV ribonucleic and deoxyribonucleic acids, and HIV reverse transcriptase. Enzyme-linked immunosorbent assays, Western blot, radioimmunoprecipitation assays, indirect immunofluorescence assays, reverse transcriptase assays, and several molecular hybridization techniques are currently available. Enzyme-linked immunosorbent, Western blot, and indirect immunofluorescence assays for HIV antibody are very sensitive, specific, and adaptable to most laboratories. An enzyme-linked immunosorbent assay for HIV antigen is also readily adaptable to most laboratories and will be commercially available soon. While the other assays are more tedious, they are valuable confirmatory tests and are suitable for reference laboratories. The biohazards of performing HIV testing can be minimized with proper biosafety measures.

Full text

PDF
125

Images in this article

126Image
on p.126

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allain J. P., Laurian Y., Paul D. A., Senn D. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs. Lancet. 1986 Nov 29;2(8518):1233–1236. doi: 10.1016/s0140-6736(86)92673-5. [DOI] [PubMed] [Google Scholar]
  2. Allan J. S., Coligan J. E., Barin F., McLane M. F., Sodroski J. G., Rosen C. A., Haseltine W. A., Lee T. H., Essex M. Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. Science. 1985 May 31;228(4703):1091–1094. doi: 10.1126/science.2986290. [DOI] [PubMed] [Google Scholar]
  3. Anderson K. C., Gorgone B. C., Marlink R. G., Ferriani R., Essex M. E., Benz P. M., Groopman J. E. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med. 1986 Oct;105(4):519–527. doi: 10.7326/0003-4819-105-4-519. [DOI] [PubMed] [Google Scholar]
  4. Asjö B., Morfeldt-Månson L., Albert J., Biberfeld G., Karlsson A., Lidman K., Fenyö E. M. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection. Lancet. 1986 Sep 20;2(8508):660–662. [PubMed] [Google Scholar]
  5. Barin F., McLane M. F., Allan J. S., Lee T. H., Groopman J. E., Essex M. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. Science. 1985 May 31;228(4703):1094–1096. doi: 10.1126/science.2986291. [DOI] [PubMed] [Google Scholar]
  6. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vézinet-Brun F., Rouzioux C. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science. 1983 May 20;220(4599):868–871. doi: 10.1126/science.6189183. [DOI] [PubMed] [Google Scholar]
  7. Barré-Sinoussi F., Mathur-Wagh U., Rey F., Brun-Vezinet F., Yancovitz S. R., Rouzioux C., Montagnier L., Mildvan D., Chermann J. C. Isolation of lymphadenopathy-associated virus (LAV) and detection of LAV antibodies from US patients with AIDS. JAMA. 1985 Mar 22;253(12):1737–1739. doi: 10.1001/jama.1985.03350360063019. [DOI] [PubMed] [Google Scholar]
  8. Bedarida G., Cambie' G., D'Agostino F., Ronsivalle M. G., Berto E., Grisi M. E., Crocchiolo P. R., Magni E. Anti-IgM screening for HIV. Lancet. 1986 Dec 20;2(8521-22):1456–1456. doi: 10.1016/s0140-6736(86)92760-1. [DOI] [PubMed] [Google Scholar]
  9. Bedarida G., Cambiè G., D'Agostino F., Ronsivalle M. G., Berto E., Grisi M. E. HIV IgM antibodies in risk groups who are seronegative on ELISA testing. Lancet. 1986 Sep 6;2(8506):570–571. doi: 10.1016/s0140-6736(86)90133-9. [DOI] [PubMed] [Google Scholar]
  10. Biberfeld G., Bredberg-Rådén U., Böttiger B., Putkonen P. O., Blomberg J., Juto P., Wadell G. Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet. 1986 Aug 2;2(8501):289–290. doi: 10.1016/s0140-6736(86)92111-2. [DOI] [PubMed] [Google Scholar]
  11. Blanton M., Balakrishnan K., Dumaswala U., Zelenski K., Greenwalt T. J. HLA antibodies in blood donors with reactive screening tests for antibody to the immunodeficiency virus. Transfusion. 1987 Jan-Feb;27(1):118–119. doi: 10.1046/j.1537-2995.1987.27187121463.x. [DOI] [PubMed] [Google Scholar]
  12. Blumberg R. S., Sandstrom E. G., Paradis T. J., Neumeyer D. N., Sarngadharan M. G., Hartshorn K. L., Byington R. E., Hirsch M. S., Schooley R. T. Detection of human T-cell lymphotropic virus type III-related antigens and anti-human T-cell lymphotropic virus type III antibodies by anticomplementary immunofluorescence. J Clin Microbiol. 1986 Jun;23(6):1072–1077. doi: 10.1128/jcm.23.6.1072-1077.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Borkowsky W., Krasinski K., Paul D., Moore T., Bebenroth D., Chandwani S. Human-immunodeficiency-virus infections in infants negative for anti-HIV by enzyme-linked immunoassay. Lancet. 1987 May 23;1(8543):1168–1171. doi: 10.1016/s0140-6736(87)92143-x. [DOI] [PubMed] [Google Scholar]
  14. Bove J. R. Transfusion-associated hepatitis and AIDS. What is the risk? N Engl J Med. 1987 Jul 23;317(4):242–245. doi: 10.1056/NEJM198707233170411. [DOI] [PubMed] [Google Scholar]
  15. Burke D. S., Brandt B. L., Redfield R. R., Lee T. H., Thorn R. M., Beltz G. A., Hung C. H. Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern Med. 1987 May;106(5):671–676. doi: 10.7326/0003-4819-106-5-671. [DOI] [PubMed] [Google Scholar]
  16. Burke D. S., Redfield R. R. False-positive Western blot tests for antibodies to HTLV-III. JAMA. 1986 Jul 18;256(3):347–347. [PubMed] [Google Scholar]
  17. Burke D. S., Redfield R. R., Putman P., Alexander S. S. Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol. 1987 Jan;25(1):81–84. doi: 10.1128/jcm.25.1.81-84.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Cable R. G., Kakaiya R. M., Roberts S. C., Martin C. R., Shafer A. W., Thaxton J. Follow-up testing of blood donors found to be enzyme immunoassay positive/Western blot negative for HTLV-III antibody. JAMA. 1986 Jul 4;256(1):40–41. [PubMed] [Google Scholar]
  19. Carlson J. R., Mertens S. C., Yee J. L., Gardner M. B., Watson-Williams E. J., Ghrayeb J., Jennings M. B., Biggar R. J. Rapid, easy, and economical screening test for antibodies to human immunodeficiency virus. Lancet. 1987 Feb 14;1(8529):361–362. doi: 10.1016/s0140-6736(87)91730-2. [DOI] [PubMed] [Google Scholar]
  20. Carter W. A., Strayer D. R., Brodsky I., Lewin M., Pellegrino M. G., Einck L., Henriques H. F., Simon G. L., Parenti D. M., Scheib R. G. Clinical, immunological, and virological effects of ampligen, a mismatched double-stranded RNA, in patients with AIDS or AIDS-related complex. Lancet. 1987 Jun 6;1(8545):1286–1292. doi: 10.1016/s0140-6736(87)90543-5. [DOI] [PubMed] [Google Scholar]
  21. Chaisson R. E., Allain J. P., Leuther M., Volberding P. A. Significant changes in HIV antigen level in the serum of patients treated with azidothymidine. N Engl J Med. 1986 Dec 18;315(25):1610–1611. doi: 10.1056/NEJM198612183152511. [DOI] [PubMed] [Google Scholar]
  22. Chiodi F., Bredberg-Råden U., Biberfeld G., Böttiger B., Albert J., Asjö B., Fenyö E. M., Norrby E. Radioimmunoprecipitation and Western blotting with sera of human immunodeficiency virus infected patients: a comparative study. AIDS Res Hum Retroviruses. 1987 Summer;3(2):165–176. doi: 10.1089/aid.1987.3.165. [DOI] [PubMed] [Google Scholar]
  23. Clavel F., Guétard D., Brun-Vézinet F., Chamaret S., Rey M. A., Santos-Ferreira M. O., Laurent A. G., Dauguet C., Katlama C., Rouzioux C. Isolation of a new human retrovirus from West African patients with AIDS. Science. 1986 Jul 18;233(4761):343–346. doi: 10.1126/science.2425430. [DOI] [PubMed] [Google Scholar]
  24. Clavel F., Mansinho K., Chamaret S., Guetard D., Favier V., Nina J., Santos-Ferreira M. O., Champalimaud J. L., Montagnier L. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N Engl J Med. 1987 May 7;316(19):1180–1185. doi: 10.1056/NEJM198705073161903. [DOI] [PubMed] [Google Scholar]
  25. Cooper D. A., Gold J., Maclean P., Donovan B., Finlayson R., Barnes T. G., Michelmore H. M., Brooke P., Penny R. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537–540. doi: 10.1016/s0140-6736(85)91205-x. [DOI] [PubMed] [Google Scholar]
  26. Couroucé A. M., Muller J. Y., Richard D. False-positive Western blot reactions to human immunodeficiency virus in blood donors. Lancet. 1986 Oct 18;2(8512):921–922. doi: 10.1016/s0140-6736(86)90443-5. [DOI] [PubMed] [Google Scholar]
  27. Essex M., Allan J., Kanki P., McLane M. F., Malone G., Kitchen L., Lee T. H. Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus. Ann Intern Med. 1985 Nov;103(5):700–703. doi: 10.7326/0003-4819-103-5-700. [DOI] [PubMed] [Google Scholar]
  28. Essex M., McLane M. F., Lee T. H., Tachibana N., Mullins J. I., Kreiss J., Kasper C. K., Poon M. C., Landay A., Stein S. F. Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacs. Science. 1983 Sep 9;221(4615):1061–1064. doi: 10.1126/science.6603659. [DOI] [PubMed] [Google Scholar]
  29. Esteban J. I., Shih J. W., Tai C. C., Bodner A. J., Kay J. W., Alter H. J. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet. 1985 Nov 16;2(8464):1083–1086. doi: 10.1016/s0140-6736(85)90683-x. [DOI] [PubMed] [Google Scholar]
  30. Falk L. A., Jr, Paul D., Landay A., Kessler H. HIV isolation from plasma of HIV-infected persons. N Engl J Med. 1987 Jun 11;316(24):1547–1548. doi: 10.1056/NEJM198706113162413. [DOI] [PubMed] [Google Scholar]
  31. Fleming D. W., Cochi S. L., Steece R. S., Hull H. F. Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex? JAMA. 1987 Aug 14;258(6):785–787. [PubMed] [Google Scholar]
  32. Franchini G., Robert-Guroff M., Aldovini A., Kan N. C., Wong-Staal F. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood. 1987 Feb;69(2):437–441. [PubMed] [Google Scholar]
  33. Fujikawa L. S., Salahuddin S. Z., Palestine A. G., Masur H., Nussenblatt R. B., Gallo R. C. Isolation of human T-lymphotropic virus type III from the tears of a patient with the acquired immunodeficiency syndrome. Lancet. 1985 Sep 7;2(8454):529–530. doi: 10.1016/s0140-6736(85)90464-7. [DOI] [PubMed] [Google Scholar]
  34. Gaines H., Albert J., von Sydow M., Sönnerborg A., Chiodi F., Ehrnst A., Strannegård O., Asjö B. HIV antigenaemia and virus isolation from plasma during primary HIV infection. Lancet. 1987 Jun 6;1(8545):1317–1318. doi: 10.1016/s0140-6736(87)90570-8. [DOI] [PubMed] [Google Scholar]
  35. Gaines H., von Sydow M., Sönnerborg A., Albert J., Czajkowski J., Pehrson P. O., Chiodi F., Moberg L., Fenyö E. M., Asjö B. Antibody response in primary human immunodeficiency virus infection. Lancet. 1987 May 30;1(8544):1249–1253. doi: 10.1016/s0140-6736(87)92696-1. [DOI] [PubMed] [Google Scholar]
  36. Gallo D., Diggs J. L., Shell G. R., Dailey P. J., Hoffman M. N., Riggs J. L. Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods. J Clin Microbiol. 1986 Jun;23(6):1049–1051. doi: 10.1128/jcm.23.6.1049-1051.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Gallo R. C., Salahuddin S. Z., Popovic M., Shearer G. M., Kaplan M., Haynes B. F., Palker T. J., Redfield R., Oleske J., Safai B. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science. 1984 May 4;224(4648):500–503. doi: 10.1126/science.6200936. [DOI] [PubMed] [Google Scholar]
  38. Gallo R. C., Wong-Staal F. A human T-lymphotropic retrovirus (HTLV-III) as the cause of the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Nov;103(5):679–689. doi: 10.7326/0003-4819-103-5-679. [DOI] [PubMed] [Google Scholar]
  39. Gartner S., Markovits P., Markovitz D. M., Kaplan M. H., Gallo R. C., Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science. 1986 Jul 11;233(4760):215–219. doi: 10.1126/science.3014648. [DOI] [PubMed] [Google Scholar]
  40. Gnann J. W., Jr, McCormick J. B., Mitchell S., Nelson J. A., Oldstone M. B. Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science. 1987 Sep 11;237(4820):1346–1349. doi: 10.1126/science.2888192. [DOI] [PubMed] [Google Scholar]
  41. Gnann J. W., Jr, Schwimmbeck P. L., Nelson J. A., Truax A. B., Oldstone M. B. Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. J Infect Dis. 1987 Aug;156(2):261–267. doi: 10.1093/infdis/156.2.261. [DOI] [PubMed] [Google Scholar]
  42. Goudsmit J., Lange J. M., Paul D. A., Dawson G. J. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. J Infect Dis. 1987 Mar;155(3):558–560. doi: 10.1093/infdis/155.3.558. [DOI] [PubMed] [Google Scholar]
  43. Goudsmit J., de Wolf F., Paul D. A., Epstein L. G., Lange J. M., Krone W. J., Speelman H., Wolters E. C., Van der Noordaa J., Oleske J. M. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. 1986 Jul 26;2(8500):177–180. doi: 10.1016/s0140-6736(86)92485-2. [DOI] [PubMed] [Google Scholar]
  44. Grady G. F., Lee V. A., Prince A. M., Gitnick G. L., Fawaz K. A., Vyas G. N., Levitt M. D., Senior J. R., Galambos J. T., Bynum T. E. Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis. 1978 Nov;138(5):625–638. doi: 10.1093/infdis/138.5.625. [DOI] [PubMed] [Google Scholar]
  45. Groopman J. E., Hartzband P. I., Shulman L., Salahuddin S. Z., Sarngadharan M. G., McLane M. F., Essex M., Gallo R. Antibody seronegative human T-lymphotropic virus type III (HTLV-III)-infected patients with acquired immunodeficiency syndrome or related disorders. Blood. 1985 Sep;66(3):742–744. [PubMed] [Google Scholar]
  46. Groopman J. E., Salahuddin S. Z., Sarngadharan M. G., Markham P. D., Gonda M., Sliski A., Gallo R. C. HTLV-III in saliva of people with AIDS-related complex and healthy homosexual men at risk for AIDS. Science. 1984 Oct 26;226(4673):447–449. doi: 10.1126/science.6093247. [DOI] [PubMed] [Google Scholar]
  47. Harper M. E., Marselle L. M., Gallo R. C., Wong-Staal F. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc Natl Acad Sci U S A. 1986 Feb;83(3):772–776. doi: 10.1073/pnas.83.3.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ho D. D., Byington R. E., Schooley R. T., Flynn T., Rota T. R., Hirsch M. S. Infrequency of isolation of HTLV-III virus from saliva in AIDS. N Engl J Med. 1985 Dec 19;313(25):1606–1606. doi: 10.1056/NEJM198512193132512. [DOI] [PubMed] [Google Scholar]
  49. Ho D. D., Rota T. R., Schooley R. T., Kaplan J. C., Allan J. D., Groopman J. E., Resnick L., Felsenstein D., Andrews C. A., Hirsch M. S. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med. 1985 Dec 12;313(24):1493–1497. doi: 10.1056/NEJM198512123132401. [DOI] [PubMed] [Google Scholar]
  50. Ho D. D., Sarngadharan M. G., Resnick L., Dimarzoveronese F., Rota T. R., Hirsch M. S. Primary human T-lymphotropic virus type III infection. Ann Intern Med. 1985 Dec;103(6 ):880–883. doi: 10.7326/0003-4819-103-6-880. [DOI] [PubMed] [Google Scholar]
  51. Ho D. D., Schooley R. T., Rota T. R., Kaplan J. C., Flynn T., Salahuddin S. Z., Gonda M. A., Hirsch M. S. HTLV-III in the semen and blood of a healthy homosexual man. Science. 1984 Oct 26;226(4673):451–453. doi: 10.1126/science.6208608. [DOI] [PubMed] [Google Scholar]
  52. Jackson B., Sannerud K., Rhame F., Tsang R., Balfour H. H., Jr Comparison of reverse transcriptase assay with the Retro-Tek viral capture assay for detection of human immunodeficiency virus. Diagn Microbiol Infect Dis. 1987 Jul;7(3):185–192. doi: 10.1016/0732-8893(87)90003-4. [DOI] [PubMed] [Google Scholar]
  53. Kaminsky L. S., McHugh T., Stites D., Volberding P., Henle G., Henle W., Levy J. A. High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A. 1985 Aug;82(16):5535–5539. doi: 10.1073/pnas.82.16.5535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kenny C., Parkin J., Underhill G., Shah N., Burnell B., Osborne E., Jeffries D. J. HIV antigen testing. Lancet. 1987 Mar 7;1(8532):565–566. doi: 10.1016/s0140-6736(87)90210-8. [DOI] [PubMed] [Google Scholar]
  55. Kitchen L. W., Barin F., Sullivan J. L., McLane M. F., Brettler D. B., Levine P. H., Essex M. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs. Nature. 1984 Nov 22;312(5992):367–369. doi: 10.1038/312367a0. [DOI] [PubMed] [Google Scholar]
  56. Koenig S., Gendelman H. E., Orenstein J. M., Dal Canto M. C., Pezeshkpour G. H., Yungbluth M., Janotta F., Aksamit A., Martin M. A., Fauci A. S. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science. 1986 Sep 5;233(4768):1089–1093. doi: 10.1126/science.3016903. [DOI] [PubMed] [Google Scholar]
  57. Koyanagi Y., Miles S., Mitsuyasu R. T., Merrill J. E., Vinters H. V., Chen I. S. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science. 1987 May 15;236(4803):819–822. doi: 10.1126/science.3646751. [DOI] [PubMed] [Google Scholar]
  58. Kumar P., Pearson J. E., Martin D. H., Leech S. H., Buisseret P. D., Bezbak H. C., Gonzalez F. M., Royer J. R., Streicher H. Z., Saxinger W. C. Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med. 1987 Feb;106(2):244–245. doi: 10.7326/0003-4819-106-2-244. [DOI] [PubMed] [Google Scholar]
  59. Kwok S., Mack D. H., Mullis K. B., Poiesz B., Ehrlich G., Blair D., Friedman-Kien A., Sninsky J. J. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol. 1987 May;61(5):1690–1694. doi: 10.1128/jvi.61.5.1690-1694.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Kühnl P., Seidl S., Holzberger G. HLA DR4 antibodies cause positive HTLV-III antibody ELISA results. Lancet. 1985 May 25;1(8439):1222–1223. doi: 10.1016/s0140-6736(85)92910-1. [DOI] [PubMed] [Google Scholar]
  61. Lange J. M., Coutinho R. A., Krone W. J., Verdonck L. F., Danner S. A., van der Noordaa J., Goudsmit J. Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus. Br Med J (Clin Res Ed) 1986 Jan 25;292(6515):228–230. doi: 10.1136/bmj.292.6515.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Lange J. M., Paul D. A., Huisman H. G., de Wolf F., van den Berg H., Coutinho R. A., Danner S. A., van der Noordaa J., Goudsmit J. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1459–1462. doi: 10.1136/bmj.293.6560.1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Lange J., Goudsmit J. Decline of antibody reactivity to HIV core protein secondary to increased production of HIV antigen. Lancet. 1987 Feb 21;1(8530):448–448. doi: 10.1016/s0140-6736(87)90148-6. [DOI] [PubMed] [Google Scholar]
  64. Levy J. A., Hoffman A. D., Kramer S. M., Landis J. A., Shimabukuro J. M., Oshiro L. S. Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science. 1984 Aug 24;225(4664):840–842. doi: 10.1126/science.6206563. [DOI] [PubMed] [Google Scholar]
  65. Levy J. A., Shimabukuro J., Hollander H., Mills J., Kaminsky L. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet. 1985 Sep 14;2(8455):586–588. [PubMed] [Google Scholar]
  66. Levy J. A., Shimabukuro J. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J Infect Dis. 1985 Oct;152(4):734–738. doi: 10.1093/infdis/152.4.734. [DOI] [PubMed] [Google Scholar]
  67. Marlink R. G., Allan J. S., McLane M. F., Essex M., Anderson K. C., Groopman J. E. Low sensitivity of ELISA testing in early HIV infection. N Engl J Med. 1986 Dec 11;315(24):1549–1549. doi: 10.1056/NEJM198612113152413. [DOI] [PubMed] [Google Scholar]
  68. Martin P. W., Burger D. R., Caouette S., Goldstein A. S., Peetoom F. Importance of confirmatory tests after strongly positive HTLV-III screening tests. N Engl J Med. 1986 Jun 12;314(24):1577–1577. doi: 10.1056/nejm198606123142412. [DOI] [PubMed] [Google Scholar]
  69. McCray E. Occupational risk of the acquired immunodeficiency syndrome among health care workers. N Engl J Med. 1986 Apr 24;314(17):1127–1132. doi: 10.1056/NEJM198604243141729. [DOI] [PubMed] [Google Scholar]
  70. Mendenhall C. L., Roselle G. A., Grossman C. J., Rouster S. D., Weesner R. E. False positive tests for HTLV-III antibodies in alcoholic patients with hepatitis. N Engl J Med. 1986 Apr 3;314(14):921–922. doi: 10.1056/NEJM198604033141412. [DOI] [PubMed] [Google Scholar]
  71. Meyer K. B., Pauker S. G. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987 Jul 23;317(4):238–241. doi: 10.1056/NEJM198707233170410. [DOI] [PubMed] [Google Scholar]
  72. Michaelis B. A., Levy J. A. Recovery of human immunodeficiency virus from serum. JAMA. 1987 Mar 13;257(10):1327–1327. doi: 10.1001/jama.1987.03390100065011. [DOI] [PubMed] [Google Scholar]
  73. Mok J. Q., Giaquinto C., De Rossi A., Grosch-Wörner I., Ades A. E., Peckham C. S. Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study. Lancet. 1987 May 23;1(8543):1164–1168. doi: 10.1016/s0140-6736(87)92142-8. [DOI] [PubMed] [Google Scholar]
  74. Monroe J. E., Andrews C., Sullivan J. L., Mulder C. Use of cytoplasmic dot-blot hybridization to detect human immunodeficiency virus RNA sequences in cultures of peripheral blood. J Infect Dis. 1987 Feb;155(2):320–322. doi: 10.1093/infdis/155.2.320. [DOI] [PubMed] [Google Scholar]
  75. Neisson-Vernant C., Arfi S., Mathez D., Leibowitch J., Monplaisir N. Needlestick HIV seroconversion in a nurse. Lancet. 1986 Oct 4;2(8510):814–814. doi: 10.1016/s0140-6736(86)90338-7. [DOI] [PubMed] [Google Scholar]
  76. Norrby E., Biberfeld G., Chiodi F., von Gegerfeldt A., Nauclér A., Parks E., Lerner R. Discrimination between antibodies to HIV and to related retroviruses using site-directed serology. Nature. 1987 Sep 17;329(6136):248–250. doi: 10.1038/329248a0. [DOI] [PubMed] [Google Scholar]
  77. Oksenhendler E., Harzic M., Le Roux J. M., Rabian C., Clauvel J. P. HIV infection with seroconversion after a superficial needlestick injury to the finger. N Engl J Med. 1986 Aug 28;315(9):582–582. doi: 10.1056/NEJM198608283150912. [DOI] [PubMed] [Google Scholar]
  78. Palca J. Safety issues raised by worker's infection with AIDS virus. Nature. 1987 Sep 17;329(6136):191–191. doi: 10.1038/329191b0. [DOI] [PubMed] [Google Scholar]
  79. Pan L. Z., Cheng-Mayer C., Levy J. A. Patterns of antibody response in individuals infected with the human immunodeficiency virus. J Infect Dis. 1987 Apr;155(4):626–632. doi: 10.1093/infdis/155.4.626. [DOI] [PubMed] [Google Scholar]
  80. Parry J. V., Mortimer P. P. Place of IgM antibody testing in HIV serology. Lancet. 1986 Oct 25;2(8513):979–980. doi: 10.1016/s0140-6736(86)90632-x. [DOI] [PubMed] [Google Scholar]
  81. Parry J. V., Perry K. R., Mortimer P. P. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet. 1987 Jul 11;2(8550):72–75. doi: 10.1016/s0140-6736(87)92737-1. [DOI] [PubMed] [Google Scholar]
  82. Paul D. A., Falk L. A., Kessler H. A., Chase R. M., Blaauw B., Chudwin D. S., Landay A. L. Correlation of serum HIV antigen and antibody with clinical status in HIV-infected patients. J Med Virol. 1987 Aug;22(4):357–363. doi: 10.1002/jmv.1890220408. [DOI] [PubMed] [Google Scholar]
  83. Peterman T. A., Lang G. R., Mikos N. J., Solomon S. L., Schable C. A., Feorino P. M., Britz J. A., Allen J. R. HTLV-III/LAV infection in hemodialysis patients. JAMA. 1986 May 2;255(17):2324–2326. [PubMed] [Google Scholar]
  84. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. doi: 10.1073/pnas.77.12.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Popovic M., Sarngadharan M. G., Read E., Gallo R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science. 1984 May 4;224(4648):497–500. doi: 10.1126/science.6200935. [DOI] [PubMed] [Google Scholar]
  86. Quinn T. C., Mann J. M., Curran J. W., Piot P. AIDS in Africa: an epidemiologic paradigm. Science. 1986 Nov 21;234(4779):955–963. doi: 10.1126/science.3022379. [DOI] [PubMed] [Google Scholar]
  87. Ranki A., Valle S. L., Krohn M., Antonen J., Allain J. P., Leuther M., Franchini G., Krohn K. Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection. Lancet. 1987 Sep 12;2(8559):589–593. doi: 10.1016/s0140-6736(87)92985-0. [DOI] [PubMed] [Google Scholar]
  88. Reesink H. W., Lelie P. N., Huisman J. G., Schaasberg W., Gonsalves M., Aaij C., Winkel I. N., van der Does J. A., Hekker A. C., Desmyter J. Evaluation of six enzyme immunoassays for antibody against human immunodeficiency virus. Lancet. 1986 Aug 30;2(8505):483–486. doi: 10.1016/s0140-6736(86)90358-2. [DOI] [PubMed] [Google Scholar]
  89. Resnick L., Veren K., Salahuddin S. Z., Tondreau S., Markham P. D. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA. 1986 Apr 11;255(14):1887–1891. [PubMed] [Google Scholar]
  90. Riggin C. H., Beltz G. A., Hung C. H., Thorn R. M., Marciani D. J. Detection of antibodies to human immunodeficiency virus by latex agglutination with recombinant antigen. J Clin Microbiol. 1987 Sep;25(9):1772–1773. doi: 10.1128/jcm.25.9.1772-1773.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Salahuddin S. Z., Groopman J. E., Markham P. D., Sarngadharan M. G., Redfield R. R., McLane M. F., Essex M., Sliski A., Gallo R. C. HTLV-III in symptom-free seronegative persons. Lancet. 1984 Dec 22;2(8417-8418):1418–1420. doi: 10.1016/s0140-6736(84)91619-2. [DOI] [PubMed] [Google Scholar]
  92. Sandstrom E. G., Schooley R. T., Ho D. D., Byington R., Sarngadharan M. G., MacLane M. E., Essex M., Gallo R. C., Hirsch M. S. Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion. 1985 Jul-Aug;25(4):308–312. doi: 10.1046/j.1537-2995.1985.25485273806.x. [DOI] [PubMed] [Google Scholar]
  93. Sarngadharan M. G., Popovic M., Bruch L., Schüpbach J., Gallo R. C. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. doi: 10.1126/science.6324345. [DOI] [PubMed] [Google Scholar]
  94. Schulz T. F., Aschauer J. M., Hengster P., Larcher C., Wachter H., Fleckenstein B., Dierich M. P. Envelope gene-derived recombinant peptide in the serodiagnosis of human immunodeficiency virus infection. Lancet. 1986 Jul 12;2(8498):111–112. doi: 10.1016/s0140-6736(86)91648-x. [DOI] [PubMed] [Google Scholar]
  95. Schüpbach J., Popovic M., Gilden R. V., Gonda M. A., Sarngadharan M. G., Gallo R. C. Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS. Science. 1984 May 4;224(4648):503–505. doi: 10.1126/science.6200937. [DOI] [PubMed] [Google Scholar]
  96. Seeff L. B., Wright E. C., Zimmerman H. J., Alter H. J., Dietz A. A., Felsher B. F., Finkelstein J. D., Garcia-Pont P., Gerin J. L., Greenlee H. B. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med. 1978 Mar;88(3):285–293. doi: 10.7326/0003-4819-88-3-285. [DOI] [PubMed] [Google Scholar]
  97. Shaw G. M., Hahn B. H., Arya S. K., Groopman J. E., Gallo R. C., Wong-Staal F. Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science. 1984 Dec 7;226(4679):1165–1171. doi: 10.1126/science.6095449. [DOI] [PubMed] [Google Scholar]
  98. Sivak S. L., Wormser G. P. Predictive value of a screening test for antibodies to HTLV-III. Am J Clin Pathol. 1986 Jun;85(6):700–703. doi: 10.1093/ajcp/85.6.700. [DOI] [PubMed] [Google Scholar]
  99. Smith D. M., Dewhurst S., Shepherd S., Volsky D. J., Goldsmith J. C. False-positive enzyme-linked immunosorbent assay reactions for antibody to human immunodeficiency virus in a population of midwestern patients with congenital bleeding disorders. Transfusion. 1987 Jan-Feb;27(1):112–112. doi: 10.1046/j.1537-2995.1987.27187121453.x. [DOI] [PubMed] [Google Scholar]
  100. Stricof R. L., Morse D. L. HTLV-III/LAV seroconversion following a deep intramuscular needlestick injury. N Engl J Med. 1986 Apr 24;314(17):1115–1115. doi: 10.1056/NEJM198604243141711. [DOI] [PubMed] [Google Scholar]
  101. Stute R. HIV antigen detection in routine blood donor screening. Lancet. 1987 Mar 7;1(8532):566–566. doi: 10.1016/s0140-6736(87)90212-1. [DOI] [PubMed] [Google Scholar]
  102. Thiry L., Sprecher-Goldberger S., Jonckheer T., Levy J., Van de Perre P., Henrivaux P., Cogniaux-LeClerc J., Clumeck N. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet. 1985 Oct 19;2(8460):891–892. doi: 10.1016/s0140-6736(85)90156-4. [DOI] [PubMed] [Google Scholar]
  103. Tsang V. C., Peralta J. M., Simons A. R. Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol. 1983;92:377–391. doi: 10.1016/0076-6879(83)92032-3. [DOI] [PubMed] [Google Scholar]
  104. Ulstrup J. C., Skaug K., Figenschau K. J., Orstavik I., Bruun J. N., Petersen G. Sensitivity of western blotting (compared with ELISA and immunofluorescence) during seroconversion after HTLV-III infection. Lancet. 1986 May 17;1(8490):1151–1152. doi: 10.1016/s0140-6736(86)91862-3. [DOI] [PubMed] [Google Scholar]
  105. Vogt M. W., Witt D. J., Craven D. E., Byington R., Crawford D. F., Schooley R. T., Hirsch M. S. Isolation of HTLV-III/LAV from cervical secretions of women at risk for AIDS. Lancet. 1986 Mar 8;1(8480):525–527. doi: 10.1016/s0140-6736(86)90884-6. [DOI] [PubMed] [Google Scholar]
  106. Wain-Hobson S., Sonigo P., Danos O., Cole S., Alizon M. Nucleotide sequence of the AIDS virus, LAV. Cell. 1985 Jan;40(1):9–17. doi: 10.1016/0092-8674(85)90303-4. [DOI] [PubMed] [Google Scholar]
  107. Wall R. A., Denning D. W., Amos A. HIV antigenaemia in acute HIV infection. Lancet. 1987 Mar 7;1(8532):566–566. doi: 10.1016/s0140-6736(87)90211-x. [DOI] [PubMed] [Google Scholar]
  108. Ward J. W., Grindon A. J., Feorino P. M., Schable C., Parvin M., Allen J. R. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. JAMA. 1986 Jul 18;256(3):357–361. [PubMed] [Google Scholar]
  109. Weber J. N., Clapham P. R., Weiss R. A., Parker D., Roberts C., Duncan J., Weller I., Carne C., Tedder R. S., Pinching A. J. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis. Lancet. 1987 Jan 17;1(8525):119–122. doi: 10.1016/s0140-6736(87)91964-7. [DOI] [PubMed] [Google Scholar]
  110. Zagury D., Bernard J., Leibowitch J., Safai B., Groopman J. E., Feldman M., Sarngadharan M. G., Gallo R. C. HTLV-III in cells cultured from semen of two patients with AIDS. Science. 1984 Oct 26;226(4673):449–451. doi: 10.1126/science.6208607. [DOI] [PubMed] [Google Scholar]
  111. van der Poel C. L., Reesink H. W., Tersmette T., Lelie P. N., Huisman H., Miedema F. Blood donations reactive for HIV in Western blot, but non-infective in culture and recipients of blood. Lancet. 1986 Sep 27;2(8509):752–753. doi: 10.1016/s0140-6736(86)90273-4. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES